These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10610497)

  • 1. In-vivo treatment with benznidazole enhances phagocytosis, parasite destruction and cytokine release by macrophages during infection with a drug-susceptible but not with a derived drug-resistant Trypansoma cruzi population.
    Murta SM; Ropert C; Alves RO; Gazzinelli RT; Romanha AJ
    Parasite Immunol; 1999 Oct; 21(10):535-44. PubMed ID: 10610497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi.
    Michailowsky V; Murta SM; Carvalho-Oliveira L; Pereira ME; Ferreira LR; Brener Z; Romanha AJ; Gazzinelli RT
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2549-56. PubMed ID: 9756754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages.
    Revelli S; Le Page C; Piaggio E; Wietzerbin J; Bottasso O
    Clin Exp Immunol; 1999 Nov; 118(2):271-7. PubMed ID: 10540190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.
    Campos MA; Closel M; Valente EP; Cardoso JE; Akira S; Alvarez-Leite JI; Ropert C; Gazzinelli RT
    J Immunol; 2004 Feb; 172(3):1711-8. PubMed ID: 14734753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
    Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
    Murta SM; Romanha AJ
    Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi.
    Lima ES; Andrade ZA; Andrade SG
    Int J Exp Pathol; 2001 Dec; 82(6):327-36. PubMed ID: 11846839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
    Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
    Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats.
    Piaggio E; Roggero E; Pitashny M; Wietzerbin J; Bottasso OA; Revelli SS
    Parasitol Res; 2001 Jul; 87(7):539-47. PubMed ID: 11484850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
    Zanusso Junior G; Massago M; Kian D; Toledo MJO
    Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
    Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO
    Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.
    Marins-Dos-Santos A; Olivieri BP; Ferreira-Reis R; de Meis J; Silva AA; de Araújo-Jorge TC; Lannes-Vieira J; Cotta-de-Almeida V
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008969. PubMed ID: 33347472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection.
    Barbosa JMC; Pedra-Rezende Y; Mata-Santos HA; Vilar-Pereira G; Melo TG; Ramos IP; Gibaldi D; Moreira OC; Nunes DF; Batista MM; Lannes-Vieira J; Daliry A; Salomão K
    Biomed Pharmacother; 2024 Jun; 175():116742. PubMed ID: 38754265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
    Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
    Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection.
    Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
    Antimicrob Agents Chemother; 2009 Jan; 53(1):174-9. PubMed ID: 19001113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.
    Silva JS; Vespa GN; Cardoso MA; Aliberti JC; Cunha FQ
    Infect Immun; 1995 Dec; 63(12):4862-7. PubMed ID: 7591147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.